Literature DB >> 23255648

Total wrist arthroplasty using the Universal 2 prosthesis.

Syam P K Morapudi1, William J Marlow, Daniel Withers, Peter Ralte, Ayman Gabr, Mohammad Waseem.   

Abstract

PURPOSE: To report outcomes of 21 total wrist arthroplasties (TWA) using the Universal 2 prosthesis.
METHODS: Five men and 14 women aged 44 to 82 (mean, 62) years underwent 21 total wrist arthroplasties for rheumatoid arthritis (n=19) and post-traumatic arthritis (n=2) by a single surgeon using the Universal 2 prosthesis. Pre- and post-operative pain and function were assessed by a single surgeon using the Disabilities of the Arm, Shoulder and Hand (DASH) score and the patient-rated wrist evaluation (PRWE) score. Range of motion, stability, dislocation rate, and neurovascular status were also assessed. Radiographs were evaluated for implant alignment and fit, screw positioning, and implant loosening.
RESULTS: The mean time to assessment of the range of motion was 3.1 (range, 1.8-3.9) years, and the mean time to assessment of the PRWE score was 4.8 (range, 2.1-7.3) years. The range of motion in each direction and the mean DASH and PRWE scores improved significantly following TWA. Two patients had restricted range of motion, which was treated by manipulation under anaesthetic (after 6 months in one and 8 weeks in the other). One patient underwent excision of a palmar bony bridge. One patient endured extensor pollicis longus rupture and underwent tendon transfer after 5 months. Radiographs revealed no evidence of implant loosening, migration, or malalignment. There was no sign of osteonecrosis in the remaining carpals or metacarpals.
CONCLUSION: The Universal 2 TWA achieved significant improvement in range of motion and functional outcome of the wrist, with reduced rates of early joint instability, dislocation, and implant loosening, compared to previous implants. The small implant size and cementless design reduce bone loss and osteonecrosis.

Entities:  

Mesh:

Year:  2012        PMID: 23255648     DOI: 10.1177/230949901202000321

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  8 in total

1.  Surgical technique: about a new total and isoelastic wrist implant (Prosthelast®).

Authors:  Santiago Salazar Botero; Yuka Igeta; Sybille Facca; Chiara Pizza; Juan José Hidalgo Diaz; Philippe A Liverneaux
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-06-28

2.  Results of the Universal 2 Prosthesis in Noninflammatory Osteoarthritic Wrists.

Authors:  M E Brinkhorst; R W Selles; J J Dias; H P Singh; R Feitz; T M Moojen; S E R Hovius
Journal:  J Wrist Surg       Date:  2017-08-24

3.  Early outcomes of arthroplasty of the first carpometacarpal joint using pyrocarbon spherical implants.

Authors:  Omar Bengezi; Anthony Vo
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

4.  High Survivorship and Few Complications With Cementless Total Wrist Arthroplasty at a Mean Followup of 9 Years.

Authors:  Joseph A Gil; Robin N Kamal; Eugene Cone; Arnold-Peter C Weiss
Journal:  Clin Orthop Relat Res       Date:  2017-07-18       Impact factor: 4.176

5.  Universal 2 Wrist Arthroplasty in Rheumatoid Arthritis.

Authors:  Sandra Pfanner; Giovanni Munz; Giulia Guidi; Massimo Ceruso
Journal:  J Wrist Surg       Date:  2017-02-17

6.  Trends in the Utilization of Total Wrist Arthroplasty versus Wrist Fusion for Treatment of Advanced Wrist Arthritis.

Authors:  Eitan Melamed; Bryan Marascalchi; Richard M Hinds; Marco Rizzo; John T Capo
Journal:  J Wrist Surg       Date:  2016-02-09

7.  Outcomes of Revision Total Wrist Arthroplasty.

Authors:  Eric R Wagner; Jason J Srnec; Michael W Fort; Laurel A Barras; Marco Rizzo
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-03-16

Review 8.  Total Wrist Arthroplasty-A Systematic Review of the Outcome, and an Introduction of FreeMove-An Approach to Improve TWA.

Authors:  Jörg Eschweiler; Jianzhang Li; Valentin Quack; Björn Rath; Alice Baroncini; Frank Hildebrand; Filippo Migliorini
Journal:  Life (Basel)       Date:  2022-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.